Danaparoid: a review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia. (vol 54, pg 903, 1997)

被引：2
|
作者：
Wilde, MI
Markham, A
机构：
来源：
DRUGS | 1998年 / 55卷 / 04期
关键词：
D O I：
10.1007/BF03259986
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：517 / 517
页数：1
相关论文
共 50 条
  • [1] Danaparoid - A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia
    Wilde, MI
    Markham, A
    DRUGS, 1997, 54 (06) : 903 - 924
  • [2] Erratum to Danaparoid: a review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia
    M. I. Wilde
    A. Markham
    Drugs, 1998, 55 : 517 - 517
  • [3] DanaparoidA Review of its Pharmacology and Clinical Use in the Management of Heparin-Induced Thrombocytopenia
    Michelle I. Wilde
    Anthony Markham
    Drugs, 1997, 54 : 903 - 924
  • [4] The combined use of iloprost and danaparoid in the surgical management of a patient with chronic thromboembolic pulmonary hypertension and heparin-induced thrombocytopenia.
    Piovella, F
    Serafini, S
    Barzaghi, N
    Barone, M
    Beltrametti, C
    Siragusa, S
    Minzioni, G
    Emmi, V
    D'Armini, A
    Viganò, M
    Braschi, A
    Ascari, E
    BLOOD, 1998, 92 (10) : 124B - 125B
  • [5] Pediatric heparin-induced thrombocytopenia: Management with Danaparoid (orgaran)
    Saxon, BR
    Black, MD
    Edgell, D
    Noel, D
    Leaker, MT
    ANNALS OF THORACIC SURGERY, 1999, 68 (03): : 1076 - 1078
  • [6] Argatroban A Review of its Use in the Management of Heparin-Induced Thrombocytopenia
    Dhillon, Sohita
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2009, 9 (04) : 261 - 282
  • [7] ArgatrobanA Review of its Use in the Management of Heparin-Induced Thrombocytopenia
    Sohita Dhillon
    American Journal of Cardiovascular Drugs, 2009, 9 : 261 - 282
  • [8] A first approach to compare efficacy and safety of lepirudin and danaparoid in patients with heparin-induced thrombocytopenia.
    Greinacher, A
    Farner, B
    Kroll, H
    Eichler, P
    BLOOD, 2000, 96 (11) : 650A - 650A
  • [9] The predictors of clinical outcome in patients with heparin-induced thrombocytopenia.
    Kelton, JG
    Hursting, MJ
    Lewis, BE
    BLOOD, 2001, 98 (11) : 36A - 36A
  • [10] Orgaran (danaparoid sodium) use in the syndrome of heparin-induced thrombocytopenia
    Magnani, HN
    PLATELETS, 1997, 8 (01) : 74 - 81
12345